Medicated Skin Care in Brazil

May 2012 | 46 pages | ID: M32439EED8AEN
Euromonitor International Ltd

Abstracts

The improved economic conditions enjoyed by lower-income consumers stimulated sales of medicated skin care products in 2011. Historically, minor parasitic infestations and fungal infections had to be ignored by a large number of Brazilians, with limited access to healthcare services and insufficient income to spend on what was perceived to be non-essential medication. This state of affairs began to change in the last decade. The growth experienced during the review period can largely be...

Euromonitor International's Medicated Skin Care in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Medicated Skin Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Aché Laboratórios Farmacêuticos SA in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 1 Aché Laboratórios Farmacêuticos SA: Key Facts
  Summary 2 Aché Laboratórios Farmacêuticos SA: Operational Indicators
Company Background
Production
  Summary 3 Aché Laboratórios Farmacêuticos SA: Production Statistics 2011
Competitive Positioning
  Summary 4 Aché Laboratórios Farmacêuticos SA: Competitive Position 2011
Bayer (brasil) SA in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 5 Bayer (Brasil) SA: Key Facts
  Summary 6 Bayer (Brasil) SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 7 Bayer (Brasil) SA: Competitive Position 2011
Ems SA in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 8 EMS SA: Key Facts
  Summary 9 EMS SA: Operational Indicators
Company Background
Production
  Summary 10 EMS SA: Production Statistics 2011
Competitive Positioning
  Summary 11 EMS SA: Competitive Position 2011
Hypermarcas SA in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 12 Hypermarcas SA: Key Facts
  Summary 13 Hypermarcas SA: Operational Indicators
Company Background
Production
  Summary 14 Hypermarcas SA: Production Statistics 2011
Competitive Positioning
  Summary 15 Hypermarcas SA: Competitive Position 2011
Medley SA Indústria Farmacêutica in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 16 Medley SA Indústria Farmacêutica: Key Facts
  Summary 17 Medley SA Indústria Farmacêutica: Operational Indicators
Company Background
Production
  Summary 18 Medley SA Indústria Farmacêutica: Production Statistics 2011
Competitive Positioning
  Summary 19 Medley SA Indústria Farmacêutica: Competitive Position 2011
Nycomed Pharma Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 20 Nycomed Pharma Ltda: Key Facts
  Summary 21 Nycomed Pharma Ltda: Operational Indicators
Company Background
Production
  Summary 22 Nycomed Pharma Ltda: Production Statistics 2011
Competitive Positioning
  Summary 23 Nycomed Pharma Ltda: Competitive Position 2011
Executive Summary
Consumer Health Continues To Show Double-digit Growth
Back To Basics: Non-prescription Drugs Are Expected To Return To OTC Status
Acquisitions Are Expected To Continue As Market Growth Attracts Investors
Mergers and Acquisitions in Parapharmacies/drugstores
A Domestic Pharmaceutical Company Is Created To Produce Biotechnological Drugs
Key Trends and Developments
Anvisa Is Expected To Change the Rules for Sales of Non-prescription Drugs
Vitamins and Dietary Supplements Suffers From Deficient Regulation
Price Control Tools Keep Adjustments Below Inflation, But Are Not Sufficient
Market Growth Drives Company Activity
Domestic Companies Join Forces To Produce Biotechnological Remedies
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
De-reimbursement
Generics
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
  Summary 24 Research Sources